China tea cups with things related to urology

20 years of Nature Reviews Urology

Our November issue marks the 20-year anniversary of Nature Reviews Urology. We celebrate this milestone with three editorials and a focus on the tumour immune microenvironment in prostate cancer.

Announcements

  • Two women converse in front of a laptop

    Nature Reviews Urology is committed to facilitating training in peer review and to ensuring that everyone involved in our peer-review process is appropriately recognised. We have, therefore, joined an initiative to allow and encourage established referees to involve one early-career researcher in our peer-review process.

Advertisement

  • Literature about prostate cancer in transgender women is growing, but many questions remain unanswered. Unique challenges exist in the identification of transgender women that can slow or even impair research advances in this field. Reframing our thinking about the identification of this population is imperative to help advance both research and clinical care.

    • Farnoosh Nik-Ahd
    • Jennifer T. Anger
    • Stephen J. Freedland
    Comment
  • When Nature Clinical Practice Urology launched in 2004, we could not have foreseen the ways in which our field has transformed. As we celebrate our 20th anniversary — traditionally, the ‘china’ anniversary — it gives us a chance to get out the special china tea service, sit back with a cup of tea and reflect on what this journal, and the editors who work on it, have achieved.

    Editorial
  • For the past 20 years, Nature Reviews Urology has evolved alongside the field, reflecting a shift towards basic research as a tool to inform clinical practice. From the latest developments in urology to the advent of telehealth, the journal has remained committed to delivering rigorous and unbiased science, accessible to a global audience.

    Editorial
  • Over the past 20 years, Nature Reviews Urology has been at the forefront of developments in the field — from championing men’s health to explaining the intricacies of the prostate cancer tumour immune microenvironment. Going forwards the journal will continue to be a leader in the field, providing an important resource for patients and physicians alike.

    Editorial